Immusoft Corporation
Total Awards:
2
Award Value:
$11,994,676
Institution type:
For profit
Short Name:
Immusoft Corporation
Awards to the Institution
| Program | Investigator | Award Title |
Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Robert Hayes | A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1 | $8,000,000 |
| Therapeutic Translational Research Projects | Robert Hayes | MPS II: Plasma cell delivery of iduronate sulfatase | $3,994,676 |
Total: $11,994,676.00 |
